VPC32183
VPC32183 is a competitive antagonist of LPA1 and LPA3 receptors. The activity of VPC32183 can inhibit lipid phosphatase 1 (LPP1), thereby preventing the activation of ERK (1/2) by dioctanoic acid diglyceride (DGPP 8:0) . By reducing the expression of LPP1, VPC32183 can further reduce DGPP 8:0-induced ERK (1/2) activation. The effects of VPC32183 suggest that it may have a positive regulatory function in cell signaling processes[1].
Product Specifications
CAS Number
717110-61-7
UNSPSC
12352005
Target
Endogenous Metabolite
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/vpc32183.html
Smiles
CCCCCCCC/C=C\CCCCCCCC(N[C@H](COP(O)(O)=O)CC1=CC=C(C=C1)OCC2=CC=CC=N2)=O
Molecular Formula
C33H51N2O6P
Molecular Weight
602.74
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
NIX, ID (BNIP3L, BNIP3A, BNIP3H, NIX, BCL2/adenovirus E1B 19kD protein-interacting protein 3-like, Adenovirus E1B19K-binding protein B5, BCL2/adenovirus E1B 19kD protein-interacting protein 3A, NIP3-like protein X) (Biotin) discontinued